Ribela Maria Teresa C P, Damiani Renata, Silva Felipe D, Lima Eliana R, Oliveira João E, Peroni Cibele N, Torjesen Peter A, Soares Carlos R, Bartolini Paolo
Biotechnology Center, Instituto de Pesquisas Energéticas e Nucleares, IPEN-CNEN/SP-Avenida Prof. Lineu Prestes, 2242-Cidade Universitária, 05508-000 São Paulo, Brazil.
Hormone Laboratory, Oslo University Hospital, 0424 Oslo, Norway.
Int J Mol Sci. 2017 Feb 3;18(2):131. doi: 10.3390/ijms18020131.
Human thyrotropin (hTSH) is a glycoprotein with three potential glycosylation sites: two in the α-subunit and one in the β-subunit. These sites are not always occupied and occupancy is frequently neglected in glycoprotein characterization, even though it is related to folding, trafficking, initiation of inflammation and host defense, as well as congenital disorders of glycosylation (CDG). For the first time -glycoprofiling analysis was applied to the site-occupancy determination of two native pituitary hTSH, in comparison with three recombinant preparations of hTSH, a widely used biopharmaceutical. A single methodology provided the: (i) average -glycan mass; (ii) mass fraction of each monosaccharide and of sulfate; and (iii) percent carbohydrate. The results indicate that the occupancy (65%-87%) and carbohydrate mass (12%-19%) can be up to 34%-57% higher in recombinant hormones. The average glycan mass is 24% lower in pituitary hTSH and contains ~3-fold fewer moles of galactose ( 0.005) and sialic acid ( 0.01). One of the two native preparations, which had the smallest glycan mass together with the lowest occupancy and GalNAc, sulfate, Gal and sialic acid contents, also presented the lowest in vivo bioactivity and circulatory half-life. The methodology described, comparing a recombinant biopharmaceutical to its native equivalent, can be applied to any physiologically or clinical relevant glycoprotein.
人促甲状腺激素(hTSH)是一种糖蛋白,有三个潜在的糖基化位点:两个在α亚基,一个在β亚基。这些位点并非总是被占据,在糖蛋白表征中,位点占据情况常常被忽视,尽管它与折叠、运输、炎症起始和宿主防御以及糖基化先天性疾病(CDG)有关。首次将糖谱分析应用于两种天然垂体hTSH的位点占据情况测定,并与三种重组hTSH制剂(一种广泛使用的生物制药)进行比较。单一方法提供了:(i)平均聚糖质量;(ii)每种单糖和硫酸盐的质量分数;以及(iii)碳水化合物百分比。结果表明,重组激素中的位点占据率(65%-87%)和碳水化合物质量(12%-19%)可能分别高出34%-57%。垂体hTSH的平均聚糖质量低24%,半乳糖(0.005)和唾液酸(0.01)的摩尔数少约3倍。两种天然制剂之一,其聚糖质量最小,位点占据率以及N-乙酰半乳糖胺、硫酸盐、半乳糖和唾液酸含量最低,其体内生物活性和循环半衰期也最低。所描述的将重组生物制药与其天然等效物进行比较的方法,可应用于任何生理或临床相关的糖蛋白。